Investment analysts at Needham & Company LLC started coverage on shares of Itron (NASDAQ:ITRI – Get Free Report) in a research note issued on Friday,Benzinga reports. The brokerage set a “buy” rating and a $124.00 price target on the scientific and technical instruments company’s stock. Needham & Company LLC’s target price would indicate a potential upside of 35.94% from the company’s previous close.
ITRI has been the subject of several other research reports. Oppenheimer upped their target price on shares of Itron from $125.00 to $133.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 18th. Johnson Rice upgraded shares of Itron from an “accumulate” rating to a “buy” rating and set a $130.00 price objective for the company in a research note on Monday, January 5th. Robert W. Baird set a $128.00 target price on shares of Itron and gave the stock an “outperform” rating in a research report on Wednesday, February 18th. Weiss Ratings lowered Itron from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Finally, Zacks Research raised Itron from a “strong sell” rating to a “hold” rating in a research report on Thursday, February 26th. Eight research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $137.10.
View Our Latest Analysis on ITRI
Itron Stock Performance
Itron (NASDAQ:ITRI – Get Free Report) last announced its quarterly earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.19 by $0.27. The business had revenue of $571.66 million for the quarter, compared to analysts’ expectations of $561.31 million. Itron had a net margin of 12.72% and a return on equity of 20.04%. The firm’s revenue for the quarter was down 6.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.35 EPS. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Analysts forecast that Itron will post 5.33 EPS for the current fiscal year.
Insider Buying and Selling at Itron
In other Itron news, SVP Donald L. Reeves III sold 5,419 shares of the firm’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $99.54, for a total value of $539,407.26. Following the completion of the sale, the senior vice president directly owned 33,140 shares of the company’s stock, valued at $3,298,755.60. This trade represents a 14.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, SVP Justin K. Patrick sold 4,930 shares of the company’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $99.54, for a total value of $490,732.20. Following the transaction, the senior vice president directly owned 34,344 shares in the company, valued at $3,418,601.76. This represents a 12.55% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 51,180 shares of company stock valued at $5,085,475 in the last quarter. Insiders own 1.45% of the company’s stock.
Hedge Funds Weigh In On Itron
Large investors have recently modified their holdings of the business. Private Trust Co. NA lifted its stake in shares of Itron by 112.4% during the 4th quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock valued at $25,000 after buying an additional 145 shares in the last quarter. Twin Peaks Wealth Advisors LLC bought a new stake in Itron during the 2nd quarter valued at $30,000. Employees Retirement System of Texas purchased a new stake in shares of Itron during the third quarter worth $32,000. Optiver Holding B.V. bought a new position in shares of Itron in the third quarter worth $36,000. Finally, Northwestern Mutual Wealth Management Co. grew its position in shares of Itron by 29.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock valued at $41,000 after purchasing an additional 101 shares in the last quarter. Hedge funds and other institutional investors own 96.19% of the company’s stock.
About Itron
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
Featured Articles
- Five stocks we like better than Itron
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- 1,500 Banks Just Handed the Fed Your Bank Account
- Silver paying 20% dividend. Plus 68% share gains
- [How To] Invest Pre-IPO In SpaceX With $100!
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.
